Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome

Kenneth A. Fowler, Corey M. Jania, Stephen L. Tilley, Angela Panoskaltsis-Mortari, Albert S. Baldwin, Jonathan S. Serody, James M. Coghill

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences